Vitenskapelige artikler
Davidson Ben, Tropé Claes G
Ovarian cancer: diagnostic, biological and prognostic aspects.
Womens Health (Lond Engl) 2014 Sep;10(5):519-33.
- PMID:
- 25335543
Wang Yun, Herrstedt Jørn, Havsteen Hanne, DePoint Christensen Rene, Mirza Mansoor Raza, Lund Bente, Maenpaa Johanna, Kristensen Gunnar
A multicenter, non-randomized, phase II study of docetaxel and carboplatin administered every 3 weeks as second line chemotherapy in patients with first relapse of platinum sensitive epithelial ovarian, peritoneal or fallopian tube cancer.
BMC Cancer 2014;14():937. Epub 2014 des 11
- PMID:
- 25494701
Sagae Satoru, Susumu Nobuyuki, Viswanathan Akila N, Aoki Daisuke, Backes Floor J, Provencher Diane M, Vaughan Michelle, Creutzberg Carien L, Kurzeder Christian, Kristensen Gunnar, Lee Chulmin, Kurtz Jean-Emmanuel, Glasspool Rosalind M, Small William
Gynecologic Cancer InterGroup (GCIG) consensus review for uterine serous carcinoma.
Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S83-9.
- PMID:
- 25341586
Amant Frédéric, Floquet Anne, Friedlander Michael, Kristensen Gunnar, Mahner Sven, Nam Eun Ji, Powell Matthew A, Ray-Coquard Isabelle, Siddiqui Nadeem, Sykes Peter, Westermann Anneke M, Seddon Beatrice
Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma.
Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S67-72.
- PMID:
- 25033257
Pujade-Lauraine Eric, Hilpert Felix, Weber Béatrice, Reuss Alexander, Poveda Andres, Kristensen Gunnar, Sorio Roberto, Vergote Ignace, Witteveen Petronella, Bamias Aristotelis, Pereira Deolinda, Wimberger Pauline, Oaknin Ana, Mirza Mansoor Raza, Follana Philippe, Bollag David, Ray-Coquard Isabelle
Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: The AURELIA open-label randomized phase III trial.
J Clin Oncol 2014 May 1;32(13):1302-8. Epub 2014 mar 17
- PMID:
- 24637997
Despierre Evelyn, Yesilyurt Betül T, Lambrechts Sandrina, Johnson Nick, Verheijen René, van der Burg Maria, Casado Antonio, Rustin Gordon, Berns Els, Leunen Karin, Amant Frédéric, Moerman Philippe, Lambrechts Diether, Vergote Ignace, EORTC GCG and EORTC GCG Translational Research Group
Epithelial ovarian cancer: rationale for changing the one-fits-all standard treatment regimen to subtype-specific treatment.
Int J Gynecol Cancer 2014 Mar;24(3):468-77.
- PMID:
- 24557434
Pettersen Erik O, Ebbesen Peter, Gieling Roben G, Williams Kaye J, Dubois Ludwig, Lambin Philippe, Ward Carol, Meehan James, Kunkler Ian H, Langdon Simon P, Ree Anne H, Flatmark Kjersti, Lyng Heidi, Calzada Maria J, Peso Luis Del, Landazuri Manuel O, Görlach Agnes, Flamm Hubert, Kieninger Jochen, Urban Gerald, Weltin Andreas, Singleton Dean C, Haider Syed, Buffa Francesca M, Harris Adrian L, Scozzafava Andrea, Supuran Claudiu T, Moser Isabella, Jobst Gerhard, Busk Morten, Toustrup Kasper, Overgaard Jens, Alsner Jan, Pouyssegur Jacques, Chiche Johanna, Mazure Nathalie, Marchiq Ibtissam, Parks Scott, Ahmed Afshan, Ashcroft Margaret, Pastorekova Silvia, Cao Yihai, Rouschop Kasper M, Wouters Brad G, Koritzinsky Marianne, Mujcic Hilda, Cojocari Dan
Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium.
J Enzyme Inhib Med Chem 2014 Oct 27. Epub 2014 okt 27
- PMID:
- 25347767
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, , , Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Vergote I, Van Nieuwenhuysen E, Lambrechts D, Wicklund KG, Eilber U, Wang-Gohrke S, Chang-Claude J, Rudolph A, Sucheston-Campbell L, Odunsi K, Moysich KB, Shvetsov YB, Thompson PJ, Goodman MT, Wilkens LR, Dörk T, Hillemanns P, Dürst M, Runnebaum IB, Bogdanova N, Pelttari LM, Nevanlinna H, Leminen A, Edwards RP, Kelley JL, Harter P, Schwaab I, Heitz F, du Bois A, Orsulic S, Lester J, Walsh C, Karlan BY, Hogdall E, Kjaer SK, Jensen A, Vierkant RA, Cunningham JM, Goode EL, Fridley BL, Southey MC, Giles GG, Bruinsma F, Wu X, Hildebrandt MA, Lu K, Liang D, Bisogna M, Levine DA, Weber RP, Schildkraut JM, Iversen ES, Berchuck A, Terry KL, Cramer DW, Tworoger SS, Poole EM, Olson SH, Orlow I, Bandera EV, Bjorge L, Tangen IL, Salvesen HB, Krakstad C, Massuger LF, Kiemeney LA, Aben KK, van Altena AM, Bean Y, Pejovic T, Kellar M, Le ND, Cook LS, Kelemen LE, Brooks-Wilson A, Lubinski J, Gronwald J, Cybulski C, Jakubowska A, Wentzensen N, Brinton LA, Lissowska J, Yang H, Nedergaard L, Lundvall L, Hogdall C, Song H, Campbell IG, Eccles D, Glasspool R, Siddiqui N, Carty K, Paul J, McNeish IA, Sieh W, McGuire V, Rothstein JH, Whittemore AS, McLaughlin JR, Risch HA, Phelan CM, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, Gentry-Maharaj A, Harrington P, Pike MC, Modugno F, Rossing MA, Ness RB, Pharoah PD, Stram DO, Wu AH, Pearce CL
Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study.
Gynecol Oncol 2015 Mar;136(3):542-8. Epub 2014 des 17
- PMID:
- 25528498
Kelemen Linda E, Terry Kathryn L, Goodman Marc T, Webb Penelope M, Bandera Elisa V, McGuire Valerie, Rossing Mary Anne, Wang Qinggang, Dicks Ed, Tyrer Jonathan P, Song Honglin, Kupryjanczyk Jolanta, Dansonka-Mieszkowska Agnieszka, Plisiecka-Halasa Joanna, Timorek Agnieszka, Menon Usha, Gentry-Maharaj Aleksandra, Gayther Simon A, Ramus Susan J, Narod Steven A, Risch Harvey A, McLaughlin John R, Siddiqui Nadeem, Glasspool Rosalind, Paul James, Carty Karen, Gronwald Jacek, Lubinski Jan, Jakubowska Anna, Cybulski Cezary, Kiemeney Lambertus A, Massuger Leon F A G, van Altena Anne M, Aben Katja K H, Olson Sara H, Orlow Irene, Cramer Daniel W, Levine Douglas A, Bisogna Maria, Giles Graham G, Southey Melissa C, Bruinsma Fiona, Kjaer Susanne K, Høgdall Estrid, Jensen Allan, Høgdall Claus K, Lundvall Lene, Engelholm Svend-Aage, Heitz Florian, du Bois Andreas, Harter Philipp, Schwaab Ira, Butzow Ralf, Nevanlinna Heli, Pelttari Liisa M, Leminen Arto, Thompson Pamela J, Lurie Galina, Wilkens Lynne R, Lambrechts Diether, Van Nieuwenhuysen Els, Lambrechts Sandrina, Vergote Ignace, Beesley Jonathan, AOCS Study Group/ACS Investigators, Fasching Peter A, Beckmann Matthias W, Hein Alexander, Ekici Arif B, Doherty Jennifer A, Wu Anna H, Pearce Celeste L, Pike Malcolm C, Stram Daniel, Chang-Claude Jenny, Rudolph Anja, Dörk Thilo, Dürst Matthias, Hillemanns Peter, Runnebaum Ingo B, Bogdanova Natalia, Antonenkova Natalia, Odunsi Kunle, Edwards Robert P, Kelley Joseph L, Modugno Francesmary, Ness Roberta B, Karlan Beth Y, Walsh Christine, Lester Jenny, Orsulic Sandra, Fridley Brooke L, Vierkant Robert A, Cunningham Julie M, Wu Xifeng, Lu Karen, Liang Dong, Hildebrandt Michelle A T, Weber Rachel Palmieri, Iversen Edwin S, Tworoger Shelley S, Poole Elizabeth M, Salvesen Helga B, Krakstad Camilla, Bjorge Line, Tangen Ingvild L, Pejovic Tanja, Bean Yukie, Kellar Melissa, Wentzensen Nicolas, Brinton Louise A, Lissowska Jolanta, Garcia-Closas Montserrat, Campbell Ian G, Eccles Diana, Whittemore Alice S, Sieh Weiva, Rothstein Joseph H, Anton-Culver Hoda, Ziogas Argyrios, Phelan Catherine M, Moysich Kirsten B, Goode Ellen L, Schildkraut Joellen M, Berchuck Andrew, Pharoah Paul D P, Sellers Thomas A, Brooks-Wilson Angela, Cook Linda S, Le Nhu D
Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk.
Mol Nutr Food Res 2014 Oct;58(10):2023-35. Epub 2014 jul 28
- PMID:
- 25066213
Ojesina Akinyemi I, Lichtenstein Lee, Freeman Samuel S, Pedamallu Chandra Sekhar, Imaz-Rosshandler Ivan, Pugh Trevor J, Cherniack Andrew D, Ambrogio Lauren, Cibulskis Kristian, Bertelsen Bjørn, Romero-Cordoba Sandra, Treviño Victor, Vazquez-Santillan Karla, Guadarrama Alberto Salido, Wright Alexi A, Rosenberg Mara W, Duke Fujiko, Kaplan Bethany, Wang Rui, Nickerson Elizabeth, Walline Heather M, Lawrence Michael S, Stewart Chip, Carter Scott L, McKenna Aaron, Rodriguez-Sanchez Iram P, Espinosa-Castilla Magali, Woie Kathrine, Bjorge Line, Wik Elisabeth, Halle Mari K, Hoivik Erling A, Krakstad Camilla, Gabiño Nayeli Belem, Gómez-Macías Gabriela Sofia, Valdez-Chapa Lezmes D, Garza-Rodríguez María Lourdes, Maytorena German, Vazquez Jorge, Rodea Carlos, Cravioto Adrian, Cortes Maria L, Greulich Heidi, Crum Christopher P, Neuberg Donna S, Hidalgo-Miranda Alfredo, Escareno Claudia Rangel, Akslen Lars A, Carey Thomas E, Vintermyr Olav K, Gabriel Stacey B, Barrera-Saldaña Hugo A, Melendez-Zajgla Jorge, Getz Gad, Salvesen Helga B, Meyerson Matthew
Landscape of genomic alterations in cervical carcinomas.
Nature 2014 Feb 20;506(7488):371-5. Epub 2013 des 25
- PMID:
- 24390348
Earp Madalene A, Kelemen Linda E, Magliocco Anthony M, Swenerton Kenneth D, Chenevix-Trench Georgia, Australian Cancer Study, Australian Ovarian Cancer Study Group, Lu Yi, Hein Alexander, Ekici Arif B, Beckmann Matthias W, Fasching Peter A, Lambrechts Diether, Despierre Evelyn, Vergote Ignace, Lambrechts Sandrina, Doherty Jennifer A, Rossing Mary Anne, Chang-Claude Jenny, Rudolph Anja, Friel Grace, Moysich Kirsten B, Odunsi Kunle, Sucheston-Campbell Lara, Lurie Galina, Goodman Marc T, Carney Michael E, Thompson Pamela J, Runnebaum Ingo B, Dürst Matthias, Hillemanns Peter, Dörk Thilo, Antonenkova Natalia, Bogdanova Natalia, Leminen Arto, Nevanlinna Heli, Pelttari Liisa M, Butzow Ralf, Bunker Clareann H, Modugno Francesmary, Edwards Robert P, Ness Roberta B, du Bois Andreas, Heitz Florian, Schwaab Ira, Harter Philipp, Karlan Beth Y, Walsh Christine, Lester Jenny, Jensen Allan, Kjær Susanne K, Høgdall Claus K, Høgdall Estrid, Lundvall Lene, Sellers Thomas A, Fridley Brooke L, Goode Ellen L, Cunningham Julie M, Vierkant Robert A, Giles Graham G, Baglietto Laura, Severi Gianluca, Southey Melissa C, Liang Dong, Wu Xifeng, Lu Karen, Hildebrandt Michelle A T, Levine Douglas A, Bisogna Maria, Schildkraut Joellen M, Iversen Edwin S, Weber Rachel Palmieri, Berchuck Andrew, Cramer Daniel W, Terry Kathryn L, Poole Elizabeth M, Tworoger Shelley S, Bandera Elisa V, Chandran Urmila, Orlow Irene, Olson Sara H, Wik Elisabeth, Salvesen Helga B, Bjorge Line, Halle Mari K, van Altena Anne M, Aben Katja K H, Kiemeney Lambertus A, Massuger Leon F A G, Pejovic Tanja, Bean Yukie T, Cybulski Cezary, Gronwald Jacek, Lubinski Jan, Wentzensen Nicolas, Brinton Louise A, Lissowska Jolanta, Garcia-Closas Montserrat, Dicks Ed, Dennis Joe, Easton Douglas F, Song Honglin, Tyrer Jonathan P, Pharoah Paul D P, Eccles Diana, Campbell Ian G, Whittemore Alice S, McGuire Valerie, Sieh Weiva, Rothstein Joseph H, Flanagan James M, Paul James, Brown Robert, Phelan Catherine M, Risch Harvey A, McLaughlin John R, Narod Steven A, Ziogas Argyrios, Anton-Culver Hoda, Gentry-Maharaj Aleksandra, Menon Usha, Gayther Simon A, Ramus Susan J, Wu Anna H, Pearce Celeste L, Pike Malcolm C, Dansonka-Mieszkowska Agnieszka, Rzepecka Iwona K, Szafron Lukasz M, Kupryjanczyk Jolanta, Cook Linda S, Le Nhu D, Brooks-Wilson Angela, Ovarian Cancer Association Consortium
Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.
Hum Genet 2014 May;133(5):481-97. Epub 2013 nov 5
- PMID:
- 24190013
Haldorsen I S, Stefansson I, Grüner R, Husby J A, Magnussen I J, Werner H M J, Salvesen Ø O, Bjørge L, Trovik J, Taxt T, Akslen L A, Salvesen H B
Increased microvascular proliferation is negatively correlated to tumour blood flow and is associated with unfavourable outcome in endometrial carcinomas.
Br J Cancer 2014 Jan 7;110(1):107-14. Epub 2013 okt 31
- PMID:
- 24178757
Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS, Kaufmann S, Hillman KM, Walpole C, Moya L, Pollock P, Jones A, Howarth K, Martin L, Gorman M, Hodgson S, , , De Polanco MM, Sans M, Carracedo A, Castellvi-Bel S, Rojas-Martinez A, Santos E, Teixeira MR, Carvajal-Carmona L, Shu XO, Long J, Zheng W, Xiang YB, , Montgomery GW, Webb PM, Scott RJ, McEvoy M, Attia J, Holliday E, Martin NG, Nyholt DR, Henders AK, Fasching PA, Hein A, Beckmann MW, Renner SP, Dörk T, Hillemanns P, Dürst M, Runnebaum I, Lambrechts D, Coenegrachts L, Schrauwen S, Amant F, Winterhoff B, Dowdy SC, Goode EL, Teoman A, Salvesen HB, Trovik J, Njolstad TS, Werner HM, Ashton K, Proietto T, Otton G, Tzortzatos G, Mints M, Tham E, , Hall P, Czene K, Liu J, Li J, Hopper JL, Southey MC, , Ekici AB, Ruebner M, Johnson N, Peto J, Burwinkel B, Marme F, Brenner H, Dieffenbach AK, Meindl A, Brauch H, , Lindblom A, Depreeuw J, Moisse M, Chang-Claude J, Rudolph A, Couch FJ, Olson JE, Giles GG, Bruinsma F, Cunningham JM, Fridley BL, Børresen-Dale AL, Kristensen VN, Cox A, Swerdlow AJ, Orr N, Bolla MK, Wang Q, Weber RP, Chen Z, Shah M, French JD, Pharoah PD, Dunning AM, Tomlinson I, Easton DF, Edwards SL, Thompson DJ, Spurdle AB
Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk.
Hum Mol Genet 2015 Mar 1;24(5):1478-92. Epub 2014 nov 6
- PMID:
- 25378557
Alonso-Alconada Lorena, Muinelo-Romay Laura, Madissoo Kadri, Diaz-Lopez Antonio, Krakstad Camilla, Trovik Jone, Wik Elisabeth, Hapangama Dharani, Coenegrachts Lieve, Cano Amparo, Gil-Moreno Antonio, Chiva Luis, Cueva Juan, Vieito Maria, Ortega Eugenia, Mariscal Javier, Colas Eva, Castellvi Josep, Cusido Maite, Dolcet Xavier, Nijman Hans W, Bosse Tjalling, Green John A, Romano Andrea, Reventos Jaume, Lopez-Lopez Rafael, Salvesen Helga B, Amant Frederic, Matias-Guiu Xavier, Moreno-Bueno Gema, Abal Miguel, ENITEC Consortium
Molecular profiling of circulating tumor cells links plasticity to the metastatic process in endometrial cancer.
Mol Cancer 2014;13():223. Epub 2014 sep 27
- PMID:
- 25261936
Alonso-Alconada Lorena, Santacana Maria, Garcia-Sanz Pablo, Muinelo-Romay Laura, Colas Eva, Mirantes Cristina, Monge Marta, Cueva Juan, Oliva Esther, Soslow Robert A, Lopez Maria Angeles, Palacios Jose, Prat Jaime, Valls Joan, Krakstad Camilla, Salvesen Helga, Gil-Moreno Antonio, Lopez-Lopez Rafael, Dolcet Xavier, Moreno-Bueno Gema, Reventos Jaume, Matias-Guiu Xavier, Abal Miguel
Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Int J Cancer 2014 Sep 13. Epub 2014 sep 13
- PMID:
- 25219463
Zhao Yu, Yang Yihua, Trovik Jone, Sun Kun, Zhou Liang, Jiang Peiyong, Lau Tat-San, Hoivik Erling A, Salvesen Helga B, Sun Hao, Wang Huating
A novel wnt regulatory axis in endometrioid endometrial cancer.
Cancer Res 2014 Sep 15;74(18):5103-17. Epub 2014 aug 1
- PMID:
- 25085246
Werner H M J, Salvesen H B
Current status of molecular biomarkers in endometrial cancer.
Curr Oncol Rep 2014 Sep;16(9):403.
- PMID:
- 25064587
Wik E, Trovik J, Kusonmano K, Birkeland E, Raeder M B, Pashtan I, Hoivik E A, Krakstad C, Werner H M J, Holst F, Mjøs S, Halle M K, Mannelqvist M, Mauland K K, Oyan A M, Stefansson I M, Petersen K, Simon R, Cherniack A D, Meyerson M, Kalland K H, Akslen L A, Salvesen H B
Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial-mesenchymal transition and PI3K alterations.
Gynecol Oncol 2014 Sep;134(3):599-606. Epub 2014 jul 1
- PMID:
- 24995579
Engerud H, Tangen I L, Berg A, Kusonmano K, Halle M K, Oyan A M, Kalland K H, Stefansson I, Trovik J, Salvesen H B, Krakstad C
High level of HSF1 associates with aggressive endometrial carcinoma and suggests potential for HSP90 inhibitors.
Br J Cancer 2014 Jul 8;111(1):78-84. Epub 2014 mai 22
- PMID:
- 24853175
Tangen Ingvild Løberg, Krakstad Camilla, Halle Mari K, Werner Henrica M J, Oyan Anne M, Kusonmano Kanthida, Petersen Kjell, Kalland Karl Henning, Akslen Lars A, Trovik Jone, Hurtado Antoni, Salvesen Helga B
Switch in FOXA1 status associates with endometrial cancer progression.
PLoS One 2014;9(5):e98069. Epub 2014 mai 21
- PMID:
- 24849812
Hoivik Erling A, Kusonmano Kanthida, Halle Mari K, Berg Anna, Wik Elisabeth, Werner Henrica M J, Petersen Kjell, Oyan Anne M, Kalland Karl-Henning, Krakstad Camilla, Trovik Jone, Widschwendter Martin, Salvesen Helga B
Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Oncotarget 2014 Feb 28;5(4):1052-61.
- PMID:
- 24658009
Werner Henrica M J, Trovik Jone, Halle Mari K, Wik Elisabeth, Akslen Lars A, Birkeland Even, Bredholt Therese, Tangen Ingvild L, Krakstad Camilla, Salvesen Helga B
Stathmin protein level, a potential predictive marker for taxane treatment response in endometrial cancer.
PLoS One 2014;9(2):e90141. Epub 2014 feb 25
- PMID:
- 24587245
Charbonneau Bridget, Block Matthew S, Bamlet William R, Vierkant Robert A, Kalli Kimberly R, Fogarty Zachary, Rider David N, Sellers Thomas A, Tworoger Shelley S, Poole Elizabeth, Risch Harvey A, Salvesen Helga B, Kiemeney Lambertus A, Baglietto Laura, Giles Graham G, Severi Gianluca, Trabert Britton, Wentzensen Nicolas, Chenevix-Trench Georgia, for AOCS/ACS group, Whittemore Alice S, Sieh Weiva, Chang-Claude Jenny, Bandera Elisa V, Orlow Irene, Terry Kathryn, Goodman Marc T, Thompson Pamela J, Cook Linda S, Rossing Mary Anne, Ness Roberta B, Narod Steven A, Kupryjanczyk Jolanta, Lu Karen, Butzow Ralf, Dörk Thilo, Pejovic Tanja, Campbell Ian, Le Nhu D, Bunker Clareann H, Bogdanova Natalia, Runnebaum Ingo B, Eccles Diana, Paul James, Wu Anna H, Gayther Simon A, Hogdall Estrid, Heitz Florian, Kaye Stanley B, Karlan Beth Y, Anton-Culver Hoda, Gronwald Jacek, Hogdall Claus K, Lambrechts Diether, Fasching Peter A, Menon Usha, Schildkraut Joellen, Pearce Celeste Leigh, Levine Douglas A, Kjaer Susanne Kruger, Cramer Daniel, Flanagan James M, Phelan Catherine M, Brown Robert, Massuger Leon F A G, Song Honglin, Doherty Jennifer A, Krakstad Camilla, Liang Dong, Odunsi Kunle, Berchuck Andrew, Jensen Allan, Lubinski Jan, Nevanlinna Heli, Bean Yukie T, Lurie Galina, Ziogas Argyrios, Walsh Christine, Despierre Evelyn, Brinton Louise, Hein Alexander, Rudolph Anja, Dansonka-Mieszkowska Agnieszka, Olson Sara H, Harter Philipp, Tyrer Jonathan, Vitonis Allison F, Brooks-Wilson Angela, Aben Katja K, Pike Malcolm C, Ramus Susan J, Wik Elisabeth, Cybulski Cezary, Lin Jie, Sucheston Lara, Edwards Robert, McGuire Valerie, Lester Jenny, du Bois Andreas, Lundvall Lene, Wang-Gohrke Shan, Szafron Lukasz M, Lambrechts Sandrina, Yang Hannah, Beckmann Matthias W, Pelttari Liisa M, van Altena Anne M, Van Den Berg David, Halle Mari K, Gentry-Maharaj Aleksandra, Schwaab Ira, Chandran Urmila, Menkiszak Janusz, Ekici Arif B, Wilkens Lynne R, Leminen Arto, Modugno Francesmary, Friel Grace, Rothstein Joseph H, Vergote Ignace, Garcia-Closas Montserrat, Hildebrandt Michelle A T, Sobiczewski Piotr, Kelemen Linda E, Pharoah Paul D P, Moysich Kirsten, Knutson Keith L, Cunningham Julie M, Fridley Brooke L, Goode Ellen L
Risk of ovarian cancer and the NF-?B pathway: genetic association with IL1A and TNFSF10.
Cancer Res 2014 Feb 1;74(3):852-61. Epub 2013 nov 22
- PMID:
- 24272484
Forskningsprosjekter
Seneffekter etter stålebehandling
Rita Steen, Oslo universitetssykehus HF
- Prosjektperiode:
- 2013 - 2020
- Deltakende helseregion:
- HV HSØ HN HMN
Moleculær biologiske studier av strålesensitivitet ved cervix cancer
Gunnar Kristensen, Oslo universitetssykehus HF
- Prosjektperiode:
- 2004 - 2022
- Deltakende helseregion:
- HSØ
Internasjonalt samarbeid
Vulvar Cancer: Molecular mechanisms and prognostic factors
Claes Gøran Trope, Oslo universitetssykehus HF
- Prosjektperiode:
- 2004 - 2020
- Deltakende helseregion:
- HSØ
Drug Resistance mechanisms of ovarian carcinoma cells in effusions
Ben Davidson, Oslo universitetssykehus HF
- Prosjektperiode:
- 2004 - 2022
- Deltakende helseregion:
- HSØ
Internasjonalt samarbeid
Arvelig Ovariecancer
Anne Dørum, Oslo universitetssykehus HF
- Prosjektperiode:
- 2004 - 2015
- Deltakende helseregion:
- HSØ
Clinical and molecular characteristics of ovarian carcinoma
Ben Davidson, Oslo universitetssykehus HF
- Prosjektperiode:
- 2004 - 2015
- Deltakende helseregion:
- HSØ
Internasjonalt samarbeid
INOVATYON
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2014 - 2024
- Deltakende helseregion:
- HV HSØ HN HMN
Internasjonalt samarbeid
Penelope
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2013 - 2017
- Deltakende helseregion:
- HV HSØ
Internasjonalt samarbeid
Adjuvant kjemoterapi ved høyrisiko Leiomyosarkom i Uterus
Gunnar S Balle Kristensen, Oslo universitetssykehus HF
- Prosjektperiode:
- 2014 - 2024
- Deltakende helseregion:
- HV HSØ
Internasjonalt samarbeid
Registrering av kreft under graviditet
Kristina Lindemann, Oslo universitetssykehus HF
- Prosjektperiode:
- 2014 - 2024
- Deltakende helseregion:
- HV HSØ HN HMN
Internasjonalt samarbeid
Residiv av gyn cancer
Ingvild Vistad, Sørlandet sykehus HF
- Prosjektperiode:
- 2012 - 2022
- Deltakende helseregion:
- HV HSØ HN HMN
EMBRACE
Kjersti Bruheim, Internasjonal institusjon
- Prosjektperiode:
- 2009 - 2024
- Deltakende helseregion:
- HSØ HMN
Internasjonalt samarbeid
ZOPTEC
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2013 - 2024
- Deltakende helseregion:
- HV HSØ
Internasjonalt samarbeid
NOVA
Katrine Woie, Internasjonal institusjon
- Prosjektperiode:
- 2013 - 2024
- Deltakende helseregion:
- HV HSØ
Internasjonalt samarbeid
MILO
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2014 - 2024
- Deltakende helseregion:
- HV HSØ
Internasjonalt samarbeid
Shape
Brynhildur Eyjolfsdottir, Internasjonal institusjon
- Prosjektperiode:
- 2014 - 2024
- Deltakende helseregion:
- HV HSØ HN HMN
Internasjonalt samarbeid
Desktop III
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2010 - 2022
- Deltakende helseregion:
- HSØ
Internasjonalt samarbeid
AGO OVAR 17
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2012 - 2022
- Deltakende helseregion:
- HV HSØ HMN
Internasjonalt samarbeid
AGO OVAR16
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2009 - 2022
- Deltakende helseregion:
- HV HSØ HMN
Internasjonalt samarbeid
Ago OVAR 12
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2009 - 2022
- Deltakende helseregion:
- HV HSØ HMN
Internasjonalt samarbeid
Aurelia
Gunnar S Balle Kristensen, Internasjonal institusjon
- Prosjektperiode:
- 2009 - 2022
- Deltakende helseregion:
- HV HSØ HN HMN
Internasjonalt samarbeid
Utfyllende informasjon
Kompetansesentret har en viktig funksjon ved å koordinere deltakelse i så vel kliniske som translasjons studier innen gynekologisk kreft.
Gynekologisk kreft er et lite fagfelt med relativt få pasienter. Det er derfor helt nødvendig å delta i internasjonalt samarbeid.
Innen klinisk forskning samarbeides via noen samarbeidsorganer:
NSGO som står for et Nordisk samarbeid.
ENGOT som står for et europeisk samarbeid
GCIG som står for Internasjonalt samarbeid.
I de fleste kliniske studier er NSGO overordnet nordisk koordinator. Vanligvis er det også europeisk og eventuelt internasjonal deltakelse.
I de enkelte kliniske studier utnevnes en norsk koordinator.
I Norge har kompetansesentret en viktig funksjon ved å koordinere norsk samarbeid.
Kompetansesentrets personale bistår ved anmeldelse til REK og utarbeidelse av nødvendig informasjonsmateriell på norsk.
Innen disse 3 samarbeidsorganisasjoner er det møter 2 ganger årlig.
Innen translasjonsstudier er det også et betydelig internasjonalt samarbeid som det framgår dels av publikasjonslisten og dels av listen over igangværende studier.